197 related articles for article (PubMed ID: 9082178)
1. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
[TBL] [Abstract][Full Text] [Related]
2. From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
JAMA; 1997 Apr; 277(15):1193-4. PubMed ID: 9103332
[No Abstract] [Full Text] [Related]
3. Teratogen update: angiotensin-converting enzyme inhibitors.
Barr M
Teratology; 1994 Dec; 50(6):399-409. PubMed ID: 7778045
[TBL] [Abstract][Full Text] [Related]
4. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
Quan A
Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
[TBL] [Abstract][Full Text] [Related]
5. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
Polifka JE
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
[TBL] [Abstract][Full Text] [Related]
6. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.
Martin RA; Jones KL; Mendoza A; Barr M; Benirschke K
Teratology; 1992 Oct; 46(4):317-21. PubMed ID: 1412062
[TBL] [Abstract][Full Text] [Related]
7. Major congenital malformations after first-trimester exposure to ACE inhibitors.
Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
[TBL] [Abstract][Full Text] [Related]
8. [Fetopathy associated with exposure to angiotensin converting enzyme inhibitors].
Neves S; Santos R; Gomes C; Correia AJ
Acta Med Port; 2010; 23(4):697-700. PubMed ID: 20687999
[TBL] [Abstract][Full Text] [Related]
9. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
Chisholm CA; Chescheir NC; Kennedy M
Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
[TBL] [Abstract][Full Text] [Related]
10. Neonatal anuria with maternal angiotensin-converting enzyme inhibition.
Rosa FW; Bosco LA; Graham CF; Milstien JB; Dreis M; Creamer J
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):371-4. PubMed ID: 2761913
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
Piper JM; Ray WA; Rosa FW
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection.
Barr M; Cohen MM
Teratology; 1991 Nov; 44(5):485-95. PubMed ID: 1771591
[TBL] [Abstract][Full Text] [Related]
13. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report].
Sadeck LS; Fernandes M; Silva SM; Trindade AA; Chia CY; Ramos JL; Leone CR
Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(6):328-32. PubMed ID: 9629744
[TBL] [Abstract][Full Text] [Related]
14. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
[TBL] [Abstract][Full Text] [Related]
15. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
Pucci M; Sarween N; Knox E; Lipkin G; Martin U
Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitor fetopathy.
Hegde AU; Parekji S; Ali US; Mehta KP
Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
[No Abstract] [Full Text] [Related]
18. Taking ACE inhibitors during pregnancy. Is it safe?
Ratnapalan S; Koren G
Can Fam Physician; 2002 Jun; 48():1047-9. PubMed ID: 12113190
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy.
Bar J; Hod M; Merlob P
Int J Risk Saf Med; 1997; 10(1):23-6. PubMed ID: 23511271
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
